Practical guide: 4 accessible biomarkers to check if your longevity protocol is working

How to use these 4 markers without overcomplicating things

The logic is simple: measure 1) vitamin D status (exposure/nutrition), 2) low‑grade systemic inflammation (hs‑CRP), 3) average glycaemic control (HbA1c) and 4) modifiable cardiovascular risk (basic lipid panel + Omega‑3 Index). Do a baseline before major changes and retest when the marker is expected to reflect the new state: ~8–12 weeks for vitamin D, ~4–12 weeks for lipids, and ~3 months for HbA1c and (once stable) hs‑CRP. These windows align with the biology of the markers and clinical monitoring recommendations for interventions, especially for lipids and HbA1c. (ods.od.nih.gov)

Vitamin D [25(OH)D]: status, practical ranges and when to repeat

The right marker for vitamin D is 25‑hydroxyvitamin D [25(OH)D]. Practically, levels ≥20 ng/mL (≥50 nmol/L) are generally considered adequate for bone health; 12–20 ng/mL (30–50 nmol/L) suggest insufficiency and <12 ng/mL (<30 nmol/L) indicate deficiency. Persistently >50–60 ng/mL (>125–150 nmol/L) can be associated with adverse effects. Be aware of relevant laboratory variability between assays. (ods.od.nih.gov)

When to test: do a baseline and repeat after 8–12 weeks of consistent supplementation—this window is when you typically approach a new steady state. In general populations without a clinical indication, many guidelines discourage routine screening; use the test when the result will change decisions (for example, dose adjustment or confirming correction of deficiency). (academic.oup.com)

Interpretation tips: small changes (±3–5 ng/mL) can reflect analytical variation, season and sun exposure. Use the same laboratory when possible and focus on direction and category (moving from 18 to 24 ng/mL is more meaningful than 34 to 31 ng/mL). (ods.od.nih.gov)

Low‑grade inflammation: hs‑CRP

hs‑CRP captures low‑grade systemic inflammation associated with cardiovascular risk. Suggested CDC/AHA categories: <1.0 mg/L low risk, 1.0–3.0 mg/L average risk, >3.0 mg/L high risk. Don’t use hs‑CRP alone to make decisions; integrate it with other factors. (ahajournals.org)

When to test: measure during a stable period (no colds, fever or recent intense training). If the value is >10 mg/L, repeat once recovered; for greater reliability, consider two measurements about two weeks apart and use the average. (ahajournals.org)

Interpretation tips: a sustained drop across categories (e.g. 2.4 to 0.9 mg/L) is more relevant than small fluctuations within the same range. Lifestyle changes (weight, activity, diet) and, in some cases, supplements can influence hs‑CRP — always assess alongside lipid profile and overall risk. (ahajournals.org)

Glucose metabolism: HbA1c

HbA1c reflects average blood glucose over roughly the previous three months. Reference categories: <5.7% normal, 5.7–6.4% prediabetes, ≥6.5% consistent with diabetes (diagnosis is clinical and requires confirmation). For longevity monitoring, the focus is whether habits and supplements keep values stably within the normal zone. (cdc.gov)

When to test: baseline and then repeat at 3 months after consistent interventions. HbA1c is useful because the average red blood cell lifespan is ~120 days and the test integrates that period. (niddk.nih.gov)

Interpretation cautions: conditions that change red blood cell lifespan (haemolytic anaemias, recent blood loss, dialysis) and haemoglobin variants can bias results. If you belong to groups with higher likelihood of variants (for example, some African, Mediterranean or Southeast Asian ancestries), confirm your lab uses NGSP‑certified methods appropriate for your profile. (niddk.nih.gov)

Heart: basic lipid panel and Omega‑3 Index

Basic lipid panel (LDL, HDL, triglycerides)

The classic panel (LDL‑C, HDL‑C, triglycerides and total cholesterol) remains central for cardiovascular risk. Generally, lower LDL is better, higher HDL is better and triglycerides <150 mg/dL are desirable. The combination “high triglycerides + low HDL” increases risk. (medlineplus.gov)

When to (re)test: after relevant changes (diet, weight loss, starting omega‑3s, or commencing medication), the largest adjustments occur between 4 and 12 weeks, so this window is reasonable to assess impact; afterwards test every 6–12 months as needed. (jacc.org)

Omega‑3 Index (percentage of EPA+DHA in red cells)

The Omega‑3 Index measures EPA+DHA percentage in red blood cell membranes and reflects longer‑term intake (several months). Research proposes three zones: <4% (higher risk), 4–8% (intermediate) and ≥8% (more favourable) in the context of coronary risk. It’s a useful marker to check whether diet and/or omega‑3 supplementation reach the target. (pubmed.ncbi.nlm.nih.gov)

When to test: baseline and repeat 3–5 months after maintaining a consistent intake pattern (fatty fish twice weekly and/or EPA+DHA supplement). Studies show this period is sufficient to stably change EPA+DHA percentage in red cells. (lpi.oregonstate.edu)

Small variations after 3–6 months: noise or real progress?

• Look for category changes or consistent direction across repeated measures rather than minimal single‑test differences (e.g. hs‑CRP from 2.1 to 0.9 mg/L is more meaningful than 2.1 to 1.8 mg/L). (ahajournals.org)
• Use the same laboratory and similar preanalytical conditions (time of day, fasting for lipids), because between‑method variation and collection context matter. For 25(OH)D, assay variability is well documented. (ods.od.nih.gov)
• For hs‑CRP, values >10 mg/L require repetition outside infection/trauma and ideally two measurements ≈2 weeks apart to average. (ahajournals.org)
• For HbA1c, very small changes (e.g. 0.1–0.2%) may lie within biological/analytical variability. If anaemia, recent bleeding or haemoglobin variants are present, confirm the lab method (NGSP) and consider repeating after resolving those factors. (niddk.nih.gov)

A simple 6‑month roadmap (practical example)

1. Week 0: baseline tests — 25(OH)D, hs‑CRP (if you are well), HbA1c, lipid panel and, if possible, Omega‑3 Index.
2. Weeks 8–12: repeat 25(OH)D if you adjusted dose; repeat lipid panel if you made clear dietary/supplement changes or started medication. (ods.od.nih.gov)
3. Month 3: repeat HbA1c (reflects the previous ~3 months). Repeat hs‑CRP if you want to confirm a trend (ideally two separate measures if values are borderline). (niddk.nih.gov)
4. Months 4–5: repeat Omega‑3 Index if you started eating fatty fish regularly and/or began EPA+DHA supplements.
5. Month 6: review all results together. Focus on direction (are you moving toward desirable zones?) and context (weight, training, sleep, medications). Update the protocol based on clear changes. (lpi.oregonstate.edu)

Summary table (useful zones and cadence)